Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia: a case series*

被引:16
作者
Brivio, Erica [1 ,2 ]
Chantrain, Christophe F. [3 ]
Gruber, Tanja A. [4 ,5 ]
Thano, Adriana [1 ]
Rialland, Fanny [6 ]
Contet, Audrey [7 ]
Elitzur, Sarah [8 ]
Dalla-Pozza, Luciano [9 ]
Kallay, Krisztian Miklos [10 ]
Li, Chi-kong [11 ]
Kato, Motohiro [12 ]
Markova, Inna [13 ]
Schmiegelow, Kjeld [14 ,15 ]
Bodmer, Nicole [16 ]
Breese, Erin H. [17 ,18 ]
Hoogendijk, Raoull [1 ]
Pieters, Rob [1 ]
Zwaan, Christian Michel [1 ,2 ]
机构
[1] Princess Maxima Ctr Pediat Oncol, Heidelberglaan 25, NL-3584 CS Utrecht, Netherlands
[2] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands
[3] CHC Clin Mt Legia Liege, Div Pediat Hematol Oncol, Liege, Belgium
[4] Stanford Sch Med, Dept Pediat, Stanford, CA 94305 USA
[5] Stanford Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[6] CHU Nantes, Dept Oncol & Hematol, Nantes, France
[7] CHRU Nancy, Dept Oncol & Hematol, Childrens Hosp, Vandoeuvre Les Nancy, France
[8] Tel Aviv Univ, Sackler Fac Med, Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol, Tel Aviv, Israel
[9] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia
[10] Cent Hosp Southern Pest, Pediat Hematol & Stem Cell Transplantat Dept, Natl Inst Hematol & Infect Dis, Budapest, Hungary
[11] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Peoples R China
[12] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan
[13] Pavlov Univ, RM Gorbacheva Mem Inst Children Oncol Hematol & T, St Petersburg, Russia
[14] Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Rigshosp, Copenhagen, Denmark
[15] Univ Copenhagen, Fac Hlth, Inst Clin Med, Copenhagen, Denmark
[16] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland
[17] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[18] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
关键词
infants; ALL; inotuzumab ozogamicin;
D O I
10.1111/bjh.17333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
No data on inotuzumab ozogamicin (InO) in infant acute lymphoblastic leukaemia (ALL) have been published to date. We collected data internationally on infants/young children (<3 years) with ALL treated with InO. Fifteen patients (median 4.4 months at diagnosis) received InO due to relapsed or refractory (R/R) disease. Median percentage of CD22(+) blasts was 72% (range 40-100%, n = 9). The median dose in the first course was 1.74 mg/m(2) (fractionated). Seven patients (47%) achieved complete remission; one additional minimal residual disease (MRD)-positive patient became MRD-negative. Six-month overall survival was 47% (95% confidence interval [CI] 27-80%). Two patients developed veno-occlusive disease after transplant. Further evaluation of InO in this subgroup of ALL is justified.
引用
收藏
页码:1172 / 1177
页数:6
相关论文
共 14 条
[1]   Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia [J].
Bhojwani, Deepa ;
Sposto, Richard ;
Shah, Nirali N. ;
Rodriguez, Vilmarie ;
Yuan, Constance ;
Stetler-Stevenson, Maryalice ;
O'Brien, Maureen M. ;
McNeer, Jennifer L. ;
Quereshi, Amrana ;
Cabannes, Aurelie ;
Schlegel, Paul ;
Rossig, Claudia ;
Dalla-Pozza, Luciano ;
August, Keith ;
Alexander, Sarah ;
Bourquin, Jean-Pierre ;
Zwaan, Michel ;
Raetz, Elizabeth A. ;
Loh, Mignon L. ;
Rheingold, Susan R. .
LEUKEMIA, 2019, 33 (04) :884-892
[2]   A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study) [J].
Brivio, Erica ;
Locatelli, Franco ;
Lopez-Yurda, Marta ;
Malone, Andrea ;
Diaz-de-Heredia, Cristina ;
Bielorai, Bella ;
Rossig, Claudia ;
van der Velden, Vincent H. J. ;
Ammerlaan, Anneke C. J. ;
Thano, Adriana ;
van der Sluis, Inge M. ;
den Boer, Monique L. ;
Chen, Ying ;
Sleight, Barbara ;
Brethon, Benoit ;
Nysom, Karsten ;
Sramkova, Lucie ;
Ora, Ingrid ;
Vinti, Luciana ;
Chen-Santel, Christiane ;
Zwaan, Christian Michel .
BLOOD, 2021, 137 (12) :1582-1590
[3]   Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia [J].
Calvo, Charlotte ;
Cabannes-Hamy, Aurelie ;
Adjaoud, Dalila ;
Bruno, Benedicte ;
Blanc, Laurence ;
Boissel, Nicolas ;
Tabone, Marie-Dominique ;
Willson-Plat, Genevieve ;
Villemonteix, Juliette ;
Baruchel, Andre ;
Brethon, Benoit .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) :E53-+
[4]   Blinatumomab for infant acute lymphoblastic leukemia [J].
Clesham, Katherine ;
Rao, Vasudha ;
Bartram, Jack ;
Ancliff, Philip ;
Ghorashian, Sara ;
O'Connor, David ;
Pavasovic, Vesna ;
Rao, Anupama ;
Samarasinghe, Sujith ;
Cummins, Michelle ;
Malone, Andrea ;
Patrick, Katharine ;
Bonney, Denise ;
James, Beki ;
Gibson, Brenda ;
Vora, Ajay .
BLOOD, 2020, 135 (17) :1501-1504
[5]   Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol (vol 30, pg 1184, 2016) [J].
Driessen, E. M. C. ;
de Lorenzo, P. ;
Campbell, M. ;
Felice, M. ;
Ferster, A. ;
Hann, I. ;
Vora, A. ;
Hovi, L. ;
Escherich, G. ;
Li, C. K. ;
Mann, G. ;
Leblanc, T. ;
Locatelli, F. ;
Biondi, A. ;
Rubnitz, J. ;
Schrappe, M. ;
Silverman, L. ;
Stary, J. ;
Suppiah, R. ;
Szczepanski, T. ;
Valsecchi, M. ;
Pieters, R. .
LEUKEMIA, 2017, 31 (12) :2854-2854
[6]   Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma [J].
Garrett, May ;
Ruiz-Garcia, Ana ;
Parivar, Kourosh ;
Hee, Brian ;
Boni, Joseph .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (03) :211-222
[7]   Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia [J].
Kantarjian, Hagop M. ;
DeAngelo, Daniel J. ;
Stelljes, Matthias ;
Martinelli, Giovanni ;
Liedtke, Michaela ;
Stock, Wendy ;
Gokbuget, Nicola ;
O'Brien, Susan ;
Wang, Kongming ;
Wang, Tao ;
Paccagnella, M. Luisa ;
Sleight, Barbara ;
Vandendries, Erik ;
Advani, Anjali S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :740-753
[8]   Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia [J].
Maude, S. L. ;
Laetsch, T. W. ;
Buechner, J. ;
Rives, S. ;
Boyer, M. ;
Bittencourt, H. ;
Bader, P. ;
Verneris, M. R. ;
Stefanski, H. E. ;
Myers, G. D. ;
Qayed, M. ;
De Moerloose, B. ;
Hiramatsu, H. ;
Schlis, K. ;
Davis, K. L. ;
Martin, P. L. ;
Nemecek, E. R. ;
Yanik, G. A. ;
Peters, C. ;
Baruchel, A. ;
Boissel, N. ;
Mechinaud, F. ;
Balduzzi, A. ;
Krueger, J. ;
June, C. H. ;
Levine, B. L. ;
Wood, P. ;
Taran, T. ;
Leung, M. ;
Mueller, K. T. ;
Zhang, Y. ;
Sen, K. ;
Lebwohl, D. ;
Pulsipher, M. A. ;
Grupp, S. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) :439-448
[9]   A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621 [J].
O'Brien, Maureen M. ;
Ji, Lingyun ;
Shah, Nirali N. ;
Rheingold, Susan R. ;
Bhojwani, Deepa ;
Yi, Joanna S. ;
Yuan, Constance M. ;
Harris, Andrew C. ;
Brown, Patrick A. ;
Borowitz, Michael J. ;
Militano, Olga ;
Devidas, Meenakshi ;
Raetz, Elizabeth A. ;
Gore, Lia ;
Loh, Mignon L. .
BLOOD, 2019, 134
[10]   Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study [J].
Pieters, Rob ;
De Lorenzo, Paola ;
Ancliffe, Philip ;
Aversa, Luis Alberto ;
Brethon, Benoit ;
Biondi, Andrea ;
Campbell, Myriam ;
Escherich, Gabriele ;
Ferster, Alina ;
Gardner, Rebecca A. ;
Kotecha, Rishi Sury ;
Lausen, Birgitte ;
Li, Chi Kong ;
Locatelli, Franco ;
Attarbaschi, Andishe ;
Peters, Christina ;
Rubnitz, Jeffrey E. ;
Silverman, Lewis B. ;
Stary, Jan ;
Szczepanski, Tomasz ;
Vora, Ajay ;
Schrappe, Martin ;
Valsecchi, Maria Grazia .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) :2246-+